Funds and prices
Overview
Actively managed equity portfolio investing worldwide in companies from the health transformation sector.
Efficient means of exploiting the potential of companies operating in the health Transformation area.
Specialised sector analysts seek out the attractive stocks in the Health Transformation area.
Investment decisions are based on a disciplined investment philosophy and fundamental research.
蜜豆视频 Asset Management classifies this fund as a Sustainability Focus Fund, which promotes environmental and social characteristics in accordance with SFDR Article 8. The research and portfolio construction processes incorporate ESG risk integration and screening and comply with 蜜豆视频 Asset Management Sustainability exclusion policy. For more information on Sustainability at 蜜豆视频, please refer to www.ubs.com/am-si-commitment.
The portfolio manager is not tied to the benchmark in terms of investment selection or weight.
The exchange rate risk between USD and CHF is largely hedged.
Benefits
The fund is pairing CIO identified investment themes with the stock selection and portfolio construction expertise of 蜜豆视频 Asset Management.
The fund taps into the knowledge of proven sector specialists.
蜜豆视频’s proprietary fundamental valuation approach allows consistent identification of the most attractive global health transformation companies.
蜜豆视频’s proprietary fundamental valuation approach allows consistent identification of the most attractive global health care companies
Investors benefit from a global investment platform of 蜜豆视频 Asset Management.
Risks
Features
| Product category |
蜜豆视频 Equity Funds
蜜豆视频 Sector Funds |
| Product domicile |
Luxembourg
|
| Portfolio management |
蜜豆视频 Asset Management (Americas) LLC, New York
|
| Fund management |
蜜豆视频 Fund Management (Luxembourg) S.A., Luxembourg
|
| Custodian bank |
蜜豆视频 Europe SE, Luxembourg Branch
|
| Representative for products established under foreign law |
蜜豆视频 Asset Management (UK) Limited
|
| Day of inception |
24 November 2021
|
| Currency of account |
USD
|
| Currency of unit class |
CHF
|
| Close of financial year |
30 November
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Management fee |
0.77% p.a.
|
| Total expense ratio (TER) |
1.04% p.a.
|
| Swing pricing |
yes
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI World Health Care (net div. reinv.)
|
| ISIN |
LU2402148659
|
| Bloomberg Ticker |
UBHCUHQ LX
|
Performance and Prices
Percentage growth
as of 03 April 2024| CHF(%) | EUR(%) | |
| YTD | ||
| 1M | ||
| 3M | -1.63 | -6.71 |
| 6M | 6.82 | 5.15 |
| 1Y | 6.05 | 7.51 |
| 2Y | -5.90 | -1.89 |
| 3Y | - | - |
| 5Y | ||
| ø p.a.5Y |
| CHF(%) | EUR(%) | |
| Q1 2023 to Q1 2024 | 10.06 | 12.30 |
| Q1 2022 to Q1 2023 | -11.22 | -8.41 |
| Q1 2021 to Q1 2022 | - | - |
| Q1 2020 to Q1 2021 | - | - |
| Q1 2019 to Q1 2020 | - | - |
Current data
| Net asset value | 03.04.2024 | CHF 94.28 |
| High - last 12 months | 10.01.2024 | CHF 98.20 |
| Low - last 12 months | 27.10.2023 | CHF 83.63 |
| Assets of the unit class in mn | 03.04.2024 | CHF 13.46 |
| Total product assets in mn | 03.04.2024 | CHF 191.31 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 29.02.2024 | 13.92% | n.a. |
| Sharpe Ratio | 29.02.2024 | -0.04 | n.a. |
| Risk Free Rate | 31.03.2024 | 0.87% | -0.06% |
Structures
Fees
Distributions
Authorisations
Literature
|
Document type
|
Document Language
|
| Prospectus |
|
| Country supplement |
|
| Key Investor Information (KIID) |
|
| Past performance |
|
| Previous performance scenario |
|
| ESG Disclosure |
|
|
Document type
|
Document Language
|
| Annual report |
|
| SFDR Periodic Report Annex |
|
| Semi-annual report |
|
